http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101293830-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_231884bb3e47510d10e3798b69c4fef0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
filingDate 2008-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13c281fc360b65085706220a09e95939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_317a5c3d7c1c6b6ea937203dfd6411a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_115acc4b56115827df8e8903e569e963
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da7c36cf35476e7184dde2c5ca44581e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62bbdcf18371319e6c2a391ea62c2268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1185b883a9535d5fb6e8a877e27df505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d03dd72a8c89b5b24dedf407205b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2c00ce306cbff9a416e88fe82b8bf7
publicationDate 2011-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101293830-B
titleOfInvention 1-oxygen-[3-aryl substituted-alkene propionyl]quinic acid compounds and uses
abstract The invention relates to 1-o-[3-aryl substituted-acrylyl]quinic acid compounds having the formula of (I), and an application thereof. The invention also relates to a preparation method of the quinic acid compounds, and intermediate compounds (II) of the quinic acid compound, i.e. 1-o-[3-aryl substituted-acrylyl]-3,4-o-isopropylidene quinic acid-1.5-lactone. The invention relates to pharmaceuticalapplication of the quinic acid compounds, and pharmaceutical compositions containing the same. The compounds having the formula (I) and the compounds having the formula of (II), and pharmaceutical salts thereof have the effects of inhibiting hepatitis B virus DNA replication and reducing hepatitis B virus surface antigen expression. Thus, the compounds having the formula of (I) and the compounds having the formula of (II) have pharmaceutical prospect application in the preparation of a drug for preventing and treating hepatitis B virus infectious disease.
priorityDate 2008-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415069083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25127155

Total number of triples: 26.